Related Experiment Video
Updated: May 21, 2026

Using Caco-2 Cells to Study Lipid Transport by the Intestine
Published on: August 20, 2015
Transport of Aflatoxin M(1) in Human Intestinal Caco-2/TC7 Cells
Francesca Caloni1, Cristina Cortinovis, Fabiola Pizzo
1Department of Health, Animal Science and Food Safety, Universitá degli Studi di Milano Milan, Italy.
Abstract:
Aflatoxin M(1) (AFM(1)) is a hydroxylated metabolite of aflatoxin B(1) (AFB(1)). After it is formed, it is secreted in the milk of mammals. Despite the potential risk of human exposure to AFM(1), data reported in literature on the metabolism, toxicity, and bioavailability of this molecule are limited and out of date. The aim of the present research was to study the absorption profile of AFM(1) and possible damage to tight junctions (TJ) of the intestinal Caco-2/TC7 clone grown on microporous filter supports. These inserts allowed for the separation of the apical and basolateral compartments which correspond to the in vivo lumen and the interstitial space/vascular systems of intestinal mucosa respectively. In this study, the Caco-2/TC7 cells were treated with different AFM(1) concentrations (10-10,000 ng/kg) for short (40 min) and long periods of time (48 h). The AFM(1) influx/efflux transport and effects on TJ were evaluated by measuring trans-epithelial electrical resistance and observing TJ protein (Zonula occludens-1 and occludin) localization. The results showed that: (i) when introduced to the apical and basolateral compartments, AFM(1) was poorly absorbed by the Caco-2/TC7 cells but its transport across the cell monolayer occurred very quickly (P(app) value of 105.10 ± 7.98 cm/s × 10(-6)). (ii) The integrity of TJ was not permanently compromised after exposure to the mycotoxin. Viability impairment or barrier damage did not occur either. The present results contribute to the evaluation of human risk exposure to AFM(1), although the AFM(1) transport mechanism need to be clarified.
Insights
Aflatoxin M1 (AFM1) is poorly absorbed by intestinal cells and does not permanently damage tight junctions, suggesting limited risk from this milk contaminant. Further research is needed to clarify its transport mechanism.
Area of Science:
- Toxicology
- Food Safety
- Cell Biology
Background:
- Aflatoxin M1 (AFM1) is a milk-borne metabolite of aflatoxin B1 (AFB1).
- Limited and outdated literature exists on AFM1 metabolism, toxicity, and bioavailability.
- Human exposure to AFM1 poses potential health risks.
Purpose of the Study:
- To investigate the absorption profile of AFM1 in intestinal cells.
- To assess the impact of AFM1 on intestinal tight junctions (TJ).
- To evaluate the potential risk of human exposure to AFM1.
Main Methods:
- Utilized Caco-2/TC7 cell monolayers grown on microporous filters.
- Exposed cells to varying AFM1 concentrations for short (40 min) and long (48 h) durations.
- Measured trans-epithelial electrical resistance and TJ protein localization (Zonula occludens-1, occludin) to assess barrier integrity and AFM1 transport.
Main Results:
- AFM1 exhibited poor absorption by Caco-2/TC7 cells but rapid transport across the monolayer (P(app) = 105.10 × 10⁻⁶ cm/s).
- Intestinal tight junction integrity was not permanently compromised by AFM1 exposure.
- No significant cell viability impairment or barrier damage was observed.
Conclusions:
- AFM1 demonstrates limited absorption and transient effects on intestinal barrier integrity.
- Findings contribute to the human risk assessment of AFM1 exposure.
- Further investigation is required to elucidate the AFM1 transport mechanism across intestinal cells.
More Related Videos
Related Concept Videos
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Transcellular Transport of Solutes
ABC Transporters: Exporter

